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Primary and secondary aortoesophageal and aortobronchial
fistulas are uniformly fatal if untreated, remain a formidable surgi-
cal problem, and carry high operative mortality in older, high-risk
patients with hemorrhagic shock or sepsis, and in those with
secondary communications between the aorta and/or graft and
the aerodigestive tract. This article represents one of the larger
series, which define the role for thoracic endovascular aortic repair
(TEVAR) for these problems. Clearly, TEVAR is becoming the
initial primary treatment, but the importance of this article is the
analysis of patient outcomes in the group treated with TEVAR
alone compared with the group who had TEVAR followed later by
aortic reconstruction and treatment of the esophageal and bron-
chial defects. The authors question the utility of TEVAR as the
only mode of therapy because of a higher 30-day and midterm
mortality in this group compared with patients treated with a
combined approach.
Based on their data, TEVAR as sole definitive treatment
should be reserved for patients with small aortobronchial commu-
nications and no CT evidence of mediastinal infection at initial
presentation or during follow up. Since patients in shock with
primary or secondary aortoesophageal fistulas had a much highercombined approach to treat them. The choice of conduit and route
for aortic reconstruction, and the specific treatment of the fistula
are dependent on patient age and comorbid conditions, the sever-
ity of infection, the location and type of fistula, and whether a
thoracic graft is already in place. Definitive treatment should follow
the precepts used to treat aortic graft-enteric erosions or fistulas in
the abdomen. Choices for aortic reconstruction include ascending
aorta to upper abdominal prosthetic bypass; or in situ replacement
with antibiotic-soaked prosthetic or homografts. The authors sug-
gest early resection of the involved segment of esophagus or lung
in patients with mediastinal sepsis. Vascularized pericardial or
pleural flaps, serratus muscle, or omentum can be used to cover the
graft or the aortic stumps. What seems crucial to improve patient
outcomes, not addressed in detail in this report, is identification of
specific factors that influence timing of the definitive open surgical
repair, and the role for suppressive antibiotics. Similar to the
treatment of abdominal aortic graft infection, one could argue for
a 6 to 8- week course of broad spectrum IV antibiotics in the
interval between TEVAR and definitive repair, followed by lifelong
oral antibiotic suppression for those with aortoesophageal fistulas,
extensive mediastinal contamination, and in situ prosthetic aortic
grafts.
